The Global Shift in Real-World Evidence: Insights from MedTech Industry Leaders

Real-World Evidence (RWE) is playing an increasingly important role in global MedTech regulatory decision-making, supporting evidence generation across the product lifecycle, from pre-market submissions to post-market surveillance.

Recent regulatory developments underline this shift, including the FDA’s final guidance on the use of RWE for medical device decision-making and the European Commission’s proposal to simplify MDR and IVDR, both of which have important implications for how real-world data (RWD) is generated and assessed.

This webcast features industry experts: Richard Holborow, Head of Clinical Compliance from Notified Body BSI, Cori Maegley, Vice President, Partnerships Management, MDIC's NEST Initiative, Marcus Torr, Head of Post Market Surveys, Purdie Pascoe and Amelia Hufford, SVP, Clinical and Regulatory Science from 3Aware. They unpack what these changes mean in practice and how MedTech manufacturers can build effective, compliant RWE strategies.

Complete the form below to watch the webcast:

Privacy Note: At Purdie Pascoe, we occasionally share the latest MedTech news and insights that we believe may be of interest to you. We will only contact you about topics relevant to your preferences. Your privacy is important to us — you can unsubscribe from our communications at any time. For more information, please see our Privacy Policy.

---